Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Greenwich LifeSciences (GLSI) Return on Equity (2020 - 2025)

Greenwich LifeSciences filings provide 6 years of Return on Equity readings, the most recent being 0.11% for Q3 2025.

  • Quarterly Return on Equity fell 9.0% to 0.11% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 0.11% through Sep 2025, down 9.0% year-over-year, with the annual reading at 0.03% for FY2024, 3.0% down from the prior year.
  • Return on Equity hit 0.11% in Q3 2025 for Greenwich LifeSciences, up from 0.13% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.0% in Q1 2021 and bottomed at 0.13% in Q2 2025.
  • Average Return on Equity over 5 years is 0.03%, with a median of 0.01% recorded in 2023.
  • The largest annual shift saw Return on Equity increased 1bps in 2021 before it dropped -11bps in 2025.
  • Greenwich LifeSciences' Return on Equity stood at 0.0% in 2021, then crashed by -231bps to 0.01% in 2022, then plummeted by -109bps to 0.01% in 2023, then tumbled by -267bps to 0.04% in 2024, then plummeted by -156bps to 0.11% in 2025.
  • Per Business Quant, the three most recent readings for GLSI's Return on Equity are 0.11% (Q3 2025), 0.13% (Q2 2025), and 0.09% (Q1 2025).